Essity AB is a leading global hygiene and health company, operating in the tissue, personal care, and incontinence markets. The company has a strong portfolio of brands including TENA, Tork, and Libero. After a period of margin compression due to raw material inflation, Essity is now benefiting from cost-saving initiatives, price increases, and a favorable mix shift towards higher-margin products. The company’s focus on innovation and sustainability positions it well for long-term growth, particularly in emerging markets where hygiene product penetration is low.
12-Month Catalysts:
- Margin recovery from cost savings and operational efficiency programs, targeting 15%+ EBITA margin.
- Strong pricing power and volume growth in professional hygiene (Tork) and incontinence care (TENA).
- Potential divestment of non-core assets or portfolio optimization to unlock value.
Key Risks:
- Raw material cost volatility (pulp, oil-based inputs) could pressure margins.
- Intense competition from private labels and other global players.
Valuation Summary: Essity trades at approximately 15x forward P/E, a discount to its historical average and peers, given the margin recovery story. With improving fundamentals, we see potential for multiple expansion.
Balance Sheet Summary: Essity has a solid investment-grade balance sheet with manageable leverage (net debt/EBITDA ~2x) and strong free cash flow generation, supporting dividends and investments.
Disclaimer: This is not personalized investment advice. Past performance is not indicative of future results. Always conduct your own research.